FR4699M - - Google Patents

Info

Publication number
FR4699M
FR4699M FR24991A FR24991A FR4699M FR 4699 M FR4699 M FR 4699M FR 24991 A FR24991 A FR 24991A FR 24991 A FR24991 A FR 24991A FR 4699 M FR4699 M FR 4699M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR24991A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR4699M publication Critical patent/FR4699M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C19/00—Acyclic saturated compounds containing halogen atoms
    • C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine
FR24991A 1964-07-17 1965-07-16 Expired FR4699M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US383502A US3261748A (en) 1964-07-17 1964-07-17 1,1,1,2-tetrafluoroethane anesthetic

Publications (1)

Publication Number Publication Date
FR4699M true FR4699M (fr) 1966-12-26

Family

ID=23513457

Family Applications (1)

Application Number Title Priority Date Filing Date
FR24991A Expired FR4699M (fr) 1964-07-17 1965-07-16

Country Status (8)

Country Link
US (1) US3261748A (fr)
BE (1) BE667017A (fr)
CH (1) CH467076A (fr)
DE (1) DE1261626B (fr)
FR (1) FR4699M (fr)
GB (1) GB1067055A (fr)
LU (1) LU49082A1 (fr)
NL (1) NL6509248A (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
ATE134509T1 (de) * 1991-06-10 1996-03-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
EP1277467B1 (fr) 1991-06-10 2006-09-20 Schering Corporation Formulations d' aérosols sans chlorofluorohydrocarbures
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
CA2455115C (fr) * 1991-12-12 2008-05-27 Glaxo Group Limited Formulation pharmaceutique en aerosol
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
NZ246421A (en) 1991-12-18 1996-05-28 Minnesota Mining & Mfg Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US7582284B2 (en) * 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
WO2005041931A2 (fr) * 2003-10-20 2005-05-12 Schering Corporation Compositions pharmaceutiques
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
MX2009008582A (es) 2007-02-11 2009-10-30 Map Pharmaceuticals Inc Metodo para la administracion terapeutica de dihidroergotamina para permitir un rapido alivio de la migraña mientras se minimiza el perfil de efectos secundarios.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA615803A (en) * 1961-03-07 D. Peschko Norman Gaseous anesthetic containing sulfur hexafluoride
US3104202A (en) * 1959-07-29 1963-09-17 Dow Chemical Co Inhalation anesthetic: 2,2-dichloro-1,1-difluoroethyl methyl ether
DE1175825B (de) * 1959-08-20 1964-08-13 E I Du Pont Des Nemours An Com Inhalationsanaesthetikumgemisch

Also Published As

Publication number Publication date
US3261748A (en) 1966-07-19
NL6509248A (fr) 1966-01-18
BE667017A (fr) 1966-01-17
CH467076A (de) 1969-01-15
LU49082A1 (fr) 1965-09-14
DE1261626B (de) 1968-02-22
GB1067055A (en) 1967-04-26

Similar Documents

Publication Publication Date Title
AU442366B2 (fr)
BE642243A (fr)
BE642367A (fr)
BE518974A (fr)
BE507097A (fr)
BE483969A (fr)
BE47396A (fr)
BE647515A (fr)
BE432268A (fr)
BE650060A (fr)
BE659779A (fr)
BE564626A (fr)
BE584699A (fr)
BE650677A (fr)
BE654503A (fr)
BE603534A (fr)
BE610935A (fr)
BE654919A (fr)
BE657917A (fr)
BE613833A (fr)
BE621510A (fr)
BE622126A (fr)
BE658017A (fr)
BE623398A (fr)
BE658101A (fr)